Dean Capital Management Invests $1.15 Million in Avantor, Inc. $AVTR

Dean Capital Management purchased a new position in Avantor, Inc. (NYSE:AVTR) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 92,349 shares of the company’s stock, valued at approximately $1,153,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Royal Bank of Canada lifted its stake in Avantor by 104.3% in the first quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock valued at $3,302,000 after buying an additional 104,022 shares during the last quarter. Empowered Funds LLC grew its position in shares of Avantor by 40.3% during the first quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock worth $286,000 after acquiring an additional 5,075 shares during the last quarter. ProShare Advisors LLC grew its position in shares of Avantor by 4.2% during the second quarter. ProShare Advisors LLC now owns 30,213 shares of the company’s stock worth $407,000 after acquiring an additional 1,204 shares during the last quarter. Allworth Financial LP increased its holdings in shares of Avantor by 110.0% in the 2nd quarter. Allworth Financial LP now owns 3,740 shares of the company’s stock worth $50,000 after acquiring an additional 1,959 shares during the period. Finally, Geode Capital Management LLC lifted its position in Avantor by 0.9% in the 2nd quarter. Geode Capital Management LLC now owns 11,905,647 shares of the company’s stock valued at $159,751,000 after purchasing an additional 109,207 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

AVTR has been the subject of a number of analyst reports. Citigroup reduced their target price on shares of Avantor from $13.00 to $11.00 and set a “neutral” rating for the company in a research note on Thursday, February 12th. Jefferies Financial Group restated an “underperform” rating and issued a $8.00 price target on shares of Avantor in a research note on Thursday, February 12th. Evercore set a $10.00 price target on Avantor in a report on Wednesday, February 11th. Robert W. Baird set a $11.00 price objective on Avantor in a research report on Thursday, February 12th. Finally, Zacks Research lowered Avantor from a “hold” rating to a “strong sell” rating in a report on Friday, February 13th. Three research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, Avantor has an average rating of “Hold” and a consensus target price of $11.80.

Insider Buying and Selling

In other news, Director Gregory L. Summe purchased 100,000 shares of the stock in a transaction dated Thursday, February 12th. The shares were bought at an average cost of $9.40 per share, for a total transaction of $940,000.00. Following the transaction, the director owned 400,000 shares in the company, valued at $3,760,000. This trade represents a 33.33% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Sanjeev K. Mehra acquired 125,000 shares of the company’s stock in a transaction dated Tuesday, March 10th. The stock was purchased at an average cost of $8.01 per share, for a total transaction of $1,001,250.00. Following the purchase, the director directly owned 475,000 shares in the company, valued at approximately $3,804,750. This represents a 35.71% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought a total of 275,000 shares of company stock valued at $2,399,250 over the last quarter. Corporate insiders own 1.20% of the company’s stock.

Avantor Stock Up 0.5%

Avantor stock opened at $7.94 on Monday. The stock has a market cap of $5.41 billion, a price-to-earnings ratio of -10.18, a PEG ratio of 3.11 and a beta of 0.97. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.70. The company’s 50-day moving average price is $10.36 and its two-hundred day moving average price is $11.66. Avantor, Inc. has a 52 week low of $7.82 and a 52 week high of $17.11.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Wednesday, February 11th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.01. The company had revenue of $1.66 billion for the quarter, compared to the consensus estimate of $1.64 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. Avantor’s revenue was down 1.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.27 EPS. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. On average, analysts expect that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.